| __timestamp | Agios Pharmaceuticals, Inc. | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 100371000 | 2395000 |
| Thursday, January 1, 2015 | 141827000 | 9057000 |
| Friday, January 1, 2016 | 220163000 | 393000 |
| Sunday, January 1, 2017 | 292681000 | 79309000 |
| Monday, January 1, 2018 | 1397000 | 134428000 |
| Tuesday, January 1, 2019 | 1317000 | 175431000 |
| Wednesday, January 1, 2020 | 2805000 | 124165000 |
| Friday, January 1, 2021 | 18777000 | 121875000 |
| Saturday, January 1, 2022 | 1704000 | 10114000 |
| Sunday, January 1, 2023 | 9504000 | 9206000 |
| Monday, January 1, 2024 | 4165000 |
Unleashing the power of data
In the dynamic world of biotechnology, Agios Pharmaceuticals, Inc. and Wave Life Sciences Ltd. have charted distinct paths over the past decade. From 2014 to 2023, Agios Pharmaceuticals experienced a dramatic 90% decrease in its cost of revenue, reflecting strategic shifts and operational efficiencies. In contrast, Wave Life Sciences saw a staggering 3,700% increase, peaking in 2019, indicative of its aggressive expansion and investment in research.
Agios Pharmaceuticals' cost of revenue peaked in 2017, while Wave Life Sciences reached its zenith in 2019. The contrasting trends highlight the diverse strategies employed by these companies in navigating the biotech landscape. As of 2023, both companies have converged to similar cost levels, suggesting a potential alignment in operational strategies. This comparison offers a fascinating glimpse into how two biotech firms adapt and evolve in a competitive market.
Analyzing Cost of Revenue: Johnson & Johnson and Wave Life Sciences Ltd.
Analyzing Cost of Revenue: United Therapeutics Corporation and Wave Life Sciences Ltd.
Cost of Revenue Comparison: Intra-Cellular Therapies, Inc. vs Agios Pharmaceuticals, Inc.
Bio-Techne Corporation vs Agios Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Halozyme Therapeutics, Inc. and Agios Pharmaceuticals, Inc.'s Expenses
Comparing Cost of Revenue Efficiency: Pharming Group N.V. vs Agios Pharmaceuticals, Inc.
Cost Insights: Breaking Down PTC Therapeutics, Inc. and Wave Life Sciences Ltd.'s Expenses
Cost of Revenue Trends: Perrigo Company plc vs Wave Life Sciences Ltd.
Agios Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Agios Pharmaceuticals, Inc. and Taro Pharmaceutical Industries Ltd.
Cost of Revenue: Key Insights for Iovance Biotherapeutics, Inc. and Wave Life Sciences Ltd.